Physician profile
Rae J Davis
NPI 1801822630
$12,446.41
in general payments reported to CMS, 2019-2025
57 companies · $1,851 in 2025
The $1,851 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,613 · 2020: $1,578 · 2021: $1,831 · 2022: $2,001 · 2023: $1,883 · 2024: $1,689 · 2025: $1,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,410 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,409.65 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,188.39 | 2019-2025 | Proclaim |
| Abbvie INC. | $1,057.32 | 2021-2025 | Qulipta, Ubrelvy |
| Collegium Pharmaceutical, INC. | $1,015.04 | 2019-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $764.36 | 2019-2025 | Relistor |
| Vertos Medical, INC. | $653.55 | 2021-2024 | Mild Device Kit |
| Ibsa Pharma INC. | $607.82 | 2020-2025 | Tirosint, Tirosint, Licart |
| Si-Bone, INC. | $604.34 | 2019-2025 | |
| Boston Scientific Corporation | $535.59 | 2019-2025 | Wavewriter Alpha Prime 16, Patient Trial Kit, Intracept |
| Pfizer INC. | $521.31 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $488.71 | 2019-2022 | |
| Lundbeck LLC | $482.12 | 2023-2025 | Vyepti |
| Allergan, INC. | $379.70 | 2019-2021 | |
| Globus Medical, INC. | $278.10 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $217.12 | 2019-2021 | |
| Lilly USA, LLC | $215.64 | 2019-2023 | Reyvow, Emgality |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rae Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.